Opsens
Company

Last deal

$10.M

Amount

Post-IPO Equity

Stage

01.12.2022

Date

9

all rounds

$74.7M

Total amount

General

About Company
Opsens offers optical pressure guidewires to improve interventional cardiology outcomes.

Industry

Sector :

Subsector :

founded date

01.01.2003

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Opsens offers high accuracy fiber optic temperature and ultra miniature pressure sensors for the Life Sciences & Medical industries. Their surface and core fiber optic temperature probes are designed for preclinical and clinical use, providing accurate measurement in MRI, NMR, and RF environments, and are optimized for easy OEM integration. Opsens’ MEMS based fiber optic pressure sensor is designed to satisfy the medical industry’s need for an extremely small catheter-tip pressure transducer that offers high frequency response, high fidelity, and artefact-free pressure measurement. The company is also involved in industrial activities in developing, manufacturing, and installing innovative fiber optic sensing solutions for critical applications.
Contacts